JOHN PAUL KUNNATH
Boston, MA 857-***-**** *******.*@************.*** www.linkedin.com/in/john-kunnath EDUCATION
Northeastern University, Boston, MA Sep 2022 - Dec 2024 Masters in Biotechnology
SRM Institute of Science and Technology, Chennai, India Jun 2018 - May 2022 Bachelor of Technology in Biotechnology
WORK EXPERIENCE
Pledge Therapeutics, Research Associate – Virology, Canton, USA Present
• Maintain and passage multiple cell lines including RPTECs, HEK293T, Sf9 insect cells and Vero cells under sterile conditions using optimized split ratios to ensure consistent growth and viability
• Perform antiviral compound screening using BKV infection assays in RPTECs and analyze efficacy through qPCR and XTT-cell toxicity assays, processing 20+ plates weekly in a 386 well high-throughput format
• Harvest and propagate BK virus from Vero cells and prepare purified virus stocks for downstream infection assays
• Optimize virus amplification protocols, stock preparation and MOI calculations, achieving reproducibility with <10% variation in viral infectivity assays, ensuring reliable viral input for dose-response evaluations
• Collaborate with cross-functional teams in the US and EU to meet hit-to-lead screening milestones and SOP updates Solid Biosciences, Analytical Development Co-op – Molecular Biology, Charlestown, USA Jan 2024 – Jul 2024
• Conducted bridging studies for PCR systems to ensure data consistency across platforms and characterized AAV capsids for accurate quantification of capsid amounts
• Developed and implemented ddPCR (Singleplex/Multiplex) assays for high-throughput sample analysis, ensuring precise and accurate molecular measurement
• Led testing of over 400+ samples using the SpectraMax i3x platform and conducted Capsid ELISA for accurate AAV capsid characterization
• Collaborated on bioenergetic assays using the Octet system to optimize cell functionality and improve assay performance
• Created and validated protocols, delivering critical data that contributed to successful R&D and Process Development outcomes
Northeastern University, Application Lab RA, Boston, USA Sep 2023 - Dec 2023
• Cultured HEK-293 cells for transfection, maintenance and development studies, for optimizing cell culture conditions for optimized protein expression
• Performed CRISPR-Cas9 gene editing to knock out gene function, assessing the results through blue-white screening for accurate evaluation of gene disruption
• Operated the AKTA Pure 25 FPLC system for protein purification using Unicorn software to achieve chromatographic separation and other maintenance related things like priming pumps, buffer flushing
• Skilled in recombinant protein extraction and proficient in SDS-PAGE for assessing protein purity, molecular weight as well as western blotting
Takeda Pharmaceuticals, Advanced Analytical Development Intern, Cambridge, USA May 2023 - Aug 2023
• Designed and optimized bioenergetic assay kits used for studying cellular metabolism and energetics, assessing mitochondrial and glycolytic functions in real-time
• Performed mammalian cell culture on various CAR-T cell products, including media preparation and critical reagent transfers
• Screened 30+ donor samples under different conditions, such as post-thaw and post-culture, to evaluate cell metabolic performance and resilience
• Executed a comparison study between different assay kits using different donor screening processes to ensure accurate metabolic profiling and helped integrate assay results for product quality evaluation
• Successfully improved assay performance, and efficiency making it a tool for evaluating cell therapy products and supporting data-driven decisions and details
SKILLS
• Protein Biochemistry: SDS-PAGE, Western Blot, Sandwich ELISA, MALDI-TOF, Column Chromatography, MSD, CE-SDS, cIEF Cell Biology: Mammalian Cell culture, Transfection, Immunofluorescence, Cell Counting, Flow Cytometry, Cryopreservation Molecular Biology: qPCR, ddPCR, RT-PCR, Gel Electrophoresis, DNA/RNA Isolation, Nanodrop, Transformation, CRISPR-Cas9
• Technical- GraphPad PRISM, JMP Suite, Java, MySQL, AutoCAD, Microsoft Suite, ELNs (IDBS, Benchling) PUBLICATIONS
• Suresh V, Kunnath J, Reddy A. Prospective dietary radical scavengers: Boon in Pharmacokinetics, overcome insulin obstruction via signaling cascade for absorption during impediments in metabolic disorder like Diabetic Mellitus. Journal of Diabetes
& Metabolic Disorders, 1149-1169, 2022.https://doi.org/10.1007/s40200-022-01038-8